United Kingdom· GB-APID-32166011000001108
Chlorphenamine 10mg/1ml solution for injection ampoules
A chlorphenamine product containing chlorphenamine, registered in United Kingdom by Wockhardt UK Ltd. The same ATC class is registered in 7 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Chlorphenamine is registered in 7 of 19 countries.
Countries holding a registration under ATC R06AB04 (chlorphenamine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Chlorphenamine · ATC R06AB04
7 / 19 countries
- Belgiumprice
- Canada
- Ireland
- Japan
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Chlorphenamine
- Manufacturer
- Wockhardt UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- R06AB04
- ATC class
- Chlorphenamine
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5012727912707
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
387 interactions on record for chlorphenamine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chlorphenamine · interactions on record
387 records
- 9 severe
- 332 moderate
- 2 minor
- 44 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Chlorphenamine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAller-chlorRugby Laboratories
- BelgiumKelargine 2 mg/5 mlCeres Pharmaceuticals
- IrelandChlorphenamine 10 mg/ml Solution for InjectionEvolan Pharma AB
- FinlandAncesolVetViva Richter GmbH
- CanadaTEVA-PHENIRAMTEVA CANADA LIMITED
- SwitzerlandArbid N, gouttes à avalerVerfora SA
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Greece · Drastino(N), Istamex
- Ireland · Chlorphenamine Evolan Pharma, Piriton Allergy
- Italy · Trimeton
- Romania · Clorfeniramin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6e6b251-1628-4928-9803-1c8e5f02bf0c GET /v1/drugs/d6e6b251-1628-4928-9803-1c8e5f02bf0c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "32166011000001108",
"desc": "Chlorphenamine 10mg/1ml solution for injection ampoules (Wockhardt UK Ltd)",
"form": "Solution for injection",
"vpid": "36137711000001100",
"source": "dmd",
"vtm_id": "775195004",
"strength": "10 mg",
"substance": "Chlorphenamine",
"ingredient": "Chlorphenamine maleate",
"supplier_code": "9301611000001105"
}See everything about chlorphenamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.